
We won the API Supplier of the Year Award for our strong commitment as a reliable API supplier to global formulating companies but also to take on the challenge of being part of the solution to address the pandemic. The nomination reflects on Dr. Reddy’s efforts to bring science, technology, and innovation together to provide a COVID-19 portfolio from prevention (SPUTNIK V) to cure (Remdesivir, Favipiravir, etc..).
At the same time, the team was able to respond to the increased demand for high-quality APIs, which resulted a two-digit growth and helped its partners ensure their medicines are available wherever and whenever needed.
To know more about our API Portfolio, write to us at: [email protected].
本網站上的任何信息,包括對任何產品或服務的任何提及,均不構成銷售要約或被解釋為代表銷售要約。受有效專利保護的產品不得提供或供應用於商業用途。但是,在某些情況下,雷迪博士可自行決定並根據當地法律要求,在存在此類監管豁免的任何地方,提供此類產品的研究數量,以根據《印度專利法》第 107A 條(Bolar 豁免)進行監管提交。購買者應對其各自市場的產品或服務(包括專利情況)進行獨立評估,並對所有與專利相關的責任負責。 Dr. Reddy's 不承擔任何明示或暗示的保證,包括但不限於適銷性、適用於特定用途和非侵權的保證。